The lack of neuropeptide Y-Y
Animals
Body Weight
/ genetics
Bone Matrix
/ metabolism
Enzyme-Linked Immunosorbent Assay
Male
Mechanical Tests
Mice
Mice, Knockout
Microscopy, Confocal
Microscopy, Electron, Transmission
Receptors, Neuropeptide Y
/ genetics
Signal Transduction
/ genetics
Spectrum Analysis, Raman
X-Ray Microtomography
Y1 receptor
biomechanical properties
bone quality
bone strength
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
06
11
2019
revised:
23
12
2019
accepted:
05
01
2020
pubmed:
22
1
2020
medline:
22
1
2021
entrez:
22
1
2020
Statut:
ppublish
Résumé
Genetic and pharmacological functional studies have provided evidence that the lack of Neuropeptide Y-Y
Identifiants
pubmed: 31960508
doi: 10.1096/fj.201902796R
doi:
Substances chimiques
Receptors, Neuropeptide Y
0
neuropeptide Y-Y1 receptor
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4163-4177Informations de copyright
© 2020 Federation of American Societies for Experimental Biology.
Références
Fuchs RK, Thompson WR, Warden SJ. 2 - Bone biology. In: Pawelec KM, Planell JA, eds. Bone Repair Biomaterials. Vol 2. 2nd ed. Woodhead Publishing; 2019:15-52.
Boskey AL, Robey PG. Chapter 11 - the regulatory role of matrix proteins in mineralization of bone. In: Marcus R, Feldman D, Dempster DW, Luckey M, Cauley JA, eds. Osteoporosis. 4th ed. San Diego: Academic Press; 2013:235-255.
Compston J. Bone quality: what is it and how is it measured? Arq Bras Endocrinol Metabol. 2006;50:579-585.
Grassel SG. The role of peripheral nerve fibers and their neurotransmitters in cartilage and bone physiology and pathophysiology. Arthritis Res Ther. 2014;16:485.
Leitao L, Alves CJ, Sousa DM, Neto E, Conceicao F, Lamghari M. The alliance between nerve fibers and stem cell populations in bone marrow: life partners in sickness and health. FASEB J. 2019;33(8):8697-8710. https://doi.org/10.1096/fj.201900454R.
Franquinho F, Liz MA, Nunes AF, Neto E, Lamghari M, Sousa MM. Neuropeptide Y and osteoblast differentiation-the balance between the neuro-osteogenic network and local control. FEBS J. 2010;277:3664-3674.
Teixeira L, Sousa DM, Nunes AF, Sousa MM, Herzog H, Lamghari M. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors. J Cell Biochem. 2009;107:908-916.
Lee NJ, Doyle KL, Sainsbury A, et al. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity. J Bone Miner Res. 2010;25:1736-1747.
Sousa DM, Conceicao F, Silva DI, et al. Ablation of Y1 receptor impairs osteoclast bone-resorbing activity. Sci Rep. 2016;6:33470.
Baldock PA, Allison SJ, Lundberg P, et al. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J Biol Chem. 2007;282:19092-19102.
Sousa DM, Baldock PA, Enriquez RF, et al. Neuropeptide Y Y1 receptor antagonism increases bone mass in mice. Bone. 2012;51:8-16.
Sousa DM, McDonald MM, Mikulec K, et al. Neuropeptide Y modulates fracture healing through Y1 receptor signaling. J Orthop Res. 2013;31:1570-1578.
Alves CJ, Alencastre IS, Neto E, et al. Bone injury and repair trigger central and peripheral NPY neuronal pathways. PLoS ONE. 2016;11:e0165465.
Lee NJ, Nguyen AD, Enriquez RF, et al. Osteoblast specific Y1 receptor deletion enhances bone mass. Bone. 2011;48:461-467.
Mertz EL, Makareeva E, Mirigian LS, et al. Makings of a brittle bone: Unexpected lessons from a low protein diet study of a mouse OI model. Matrix Biol. 2016;52-54:29-42.
Bhan A, Qiu S, Rao SD. Bone histomorphometry in the evaluation of osteomalacia. Bone Rep. 2018;8:125-134.
Treager C, Isales C. Osteomalacia and rickets. In: Eltorai AEM, Eberson CP, Daniels AH, eds. Orthopedic Surgery Clerkship: A Quick Reference Guide for Senior Medical Students. Cham: Springer International Publishing; 2017:743-748.
Licata A. Bone density vs bone quality: what's a clinician to do? Cleve Clin J Med. 2009;76:331-336.
Stark Z, Savarirayan R. Osteopetrosis. Orphanet J Rare Dis. 2009;4:5.
Jin A, Cobb J, Hansen U, et al. The effect of long-term bisphosphonate therapy on trabecular bone strength and microcrack density. Bone Joint Res. 2017;6:602-609.
Brodt MD, Ellis CB, Silva MJ. Growing C57Bl/6 mice increase whole bone mechanical properties by increasing geometric and material properties. J Bone Miner Res. 1999;14:2159-2166.
Ferguson VL, Ayers RA, Bateman TA, Simske SJ. Bone development and age-related bone loss in male C57BL/6J mice. Bone. 2003;33:387-398.
Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010;25:1468-1486.
Junqueira LC, Cossermelli W, Brentani R. Differential staining of collagens type I, II and III by Sirius Red and polarization microscopy. Arch Histol Jpn. 1978;41:267-274.
Bi X, Patil CA, Lynch CC, Pharr GM, Mahadevan-Jansen A, Nyman JS. Raman and mechanical properties correlate at whole bone- and tissue-levels in a genetic mouse model. J Biomech. 2011;44:297-303.
Jepsen KJ, Silva MJ, Vashishth D, Guo XE, van der Meulen MC. Establishing biomechanical mechanisms in mouse models: practical guidelines for systematically evaluating phenotypic changes in the diaphyses of long bones. J Bone Miner Res. 2015;30:951-966.
Akhter MP, Wells DJ, Short SJ, et al. Bone biomechanical properties in LRP5 mutant mice. Bone. 2004;35:162-169.
Zengin A, Zhang L, Herzog H, Baldock PA, Sainsbury A. Neuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat. Trends Endocrinol Metab. 2010;21:411-418.
Zhang L, Macia L, Turner N, et al. Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion. Int J Obes (Lond). 2010;34:357-373.
Donnelly E. Methods for assessing bone quality: a review. Clin Orthop Relat Res. 2011;469:2128-2138.
Mandair GS, Morris MD. Contributions of Raman spectroscopy to the understanding of bone strength. Bonekey Rep. 2015;4:620.
Goodyear SR, Aspden RM. Raman microscopy and bone. Methods Mol Biol. 2019;1914:651-659.
Kremer R, Gilsanz V. Fat and bone: an odd couple. Front Endocrinol (Lausanne). 2015;6:190.
Allison SJ, Baldock PA, Enriquez RF, et al. Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis. J Bone Miner Res. 2009;24:294-304.
Riggs BL, Hodgson SF, O'Fallon WM, et al. Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med. 1990;322:802-809.
McNally EA, Schwarcz HP, Botton GA, Arsenault AL. A model for the ultrastructure of bone based on electron microscopy of ion-milled sections. PLoS ONE. 2012;7:e29258.
Schwarcz HP, Abueidda D, Jasiuk I. The ultrastructure of bone and its relevance to mechanical properties. Frontiers Physics. 2017;5:39. https://doi.org/10.3389/fphy.2017.00039.
Oest ME, Gong B, Esmonde-White K, et al. Parathyroid hormone attenuates radiation-induced increases in collagen crosslink ratio at periosteal surfaces of mouse tibia. Bone. 2016;86:91-97.
Vijayan V, Gupta S. Role of osteocytes in mediating bone mineralization during hyperhomocysteinemia. J Endocrinol. 2017;233:243-255.
Dole NS, Mazur CM, Acevedo C, et al. Osteocyte-intrinsic TGF-beta signaling regulates bone quality through perilacunar/canalicular remodeling. Cell Rep. 2017;21:2585-2596.
Bonewald LF. The amazing osteocyte. J Bone Miner Res. 2011;26:229-238.
Igwe JC, Jiang X, Paic F, et al. Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity. J Cell Biochem. 2009;108:621-630.